Product assessment for SABIC CYCOLAC HMG94MD, an acrylonitrile-butadiene-styrene injection moulding grade supplied within the manufacturer’s medical-device resin portfolio. The grade is typically evaluated for thin-wall diagnostic housings, single-use surgical instrument enclosures, and drug-delivery system components where melt processability, dimensional repeatability, and biocompatibility documentation are concurrent requirements. The material is differentiated from general-purpose ABS by supplier-controlled manufacturing consistency and from standard CYCOLAC MG94MD by a higher melt mass-flow rate intended to reduce filling pressure in narrow flow channels. All values in this document are representative of conditioned specimens or standard processing practice; the controlling data remain the production lot certificate of analysis and the current grade datasheet.

At the molecular level, ABS comprises a continuous styrene-acrylonitrile copolymer phase with grafted and dispersed polybutadiene rubber particles. The high-flow character of HMG94MD is obtained primarily through controlled molar mass distribution rather than elevated processing aids. This architecture lowers the low-shear melt viscosity while retaining the glass transition region and tensile modulus typical of medical ABS. The trade-off is reduced notched Izod impact and a higher ductile-to-brittle transition relative to CYCOLAC MG94MD, a point that must be evaluated for snap-fit geometries. Melt viscosity data should be obtained for the actual production lot; published comparative data for this specific configuration is limited. Capillary rheometry according to ISO 11443:2014 is the preferred method for generating viscosity curves for flow simulation, typically at 230 °C, 250 °C, and 270 °C with shear rates from 50 s⁻¹ to 5000 s⁻¹.

On production-scale electric injection moulding machines with 800 kN clamp force, the main failure modes observed with high-flow medical ABS are splay from insufficient drying, jetting from undersized gates, and short shots in cold runner tips due to frozen skin. Batch-to-batch variance in melt mass-flow rate for high-flow grades should be monitored because a shift of ±5% can alter fill time and cavity pressure in thin-wall tools. Use of a weigh scale checker at the hopper and a melt pressure transducer at the nozzle provides early detection of viscosity shift.

What Distinguishes the HMG94MD Flow Path from Standard CYCOLAC MG94MD?

The following table compares representative values for HMG94MD and CYCOLAC MG94MD. These are not specification limits and should not be used for final design; they are supplied to illustrate the trade-off between flow and impact.

The 21 g/10 min versus 10 g/10 min difference in melt mass-flow rate translates into shorter fill times and reduced clamp force demand in thin-wall tools, but the lower impact value restricts the grade’s use in load-bearing snap fits that require high-extension deformation. Cavity-pressure transducers should be used to compare actual pressure drop; a simple ratio of melt mass-flow rate values is not a substitute for confirmed short-shot studies. Relative to flame-retardant CYCOLAC FR15U, HMG94MD is typically classified only at UL 94 HB; it is not a substitute for enclosures requiring V-0 at 1.5 mm. Compared with CYCOLAC MG47MD, the high-flow grade gives thinner wall fill but sacrifices notched Izod; MG47MD remains the better candidate for thick load-bearing retainers where impact values above 30 kJ/m² are specified.

Moisture control is the primary process hazard. ABS resin acquires moisture under ambient storage; if the material is not dried, steam expansion at the melt front generates splay, weak weld lines, and embrittlement. The material should be dried in a desiccant-bed dryer with a supply air dew point of −30 °C or lower, at 80–85 °C for 3–4 h, to a residual moisture target below 0.05% by weight. Hopper dryers without a desiccant rotor are not sufficient when relative humidity exceeds 60%. Measurement of residual moisture by Karl Fischer titration is preferred over loss-on-drying because the latter can be affected by volatile additives. If masterbatch is added, a co-rotating twin-screw extruder with 30:1–40:1 L/D and vacuum venting at 0.08 MPa reduced pressure is common for dispersion; melt temperature should not exceed 260 °C to protect the butadiene phase from thermal oxidation.

Regrind incorporation is limited. Unsorted regrind from medical moulding should not be used unless dedicated closed-loop recycling is validated. Regrind content up to 20 wt% is common for non-validated technical parts; for medical devices, regrind use may be prohibited by the device manufacturer’s quality system unless equivalence to virgin material is established under ISO 13485:2016. If regrind is allowed, the ground material should be dried to the same moisture target and monitored for dust content and particle size distribution.

Injection Pressure, Screw Design, and Clamp Force Requirements for Thin-Wall Medical Housings

Production-scale moulding of HMG94MD on electric or hydraulic injection moulding machines uses a rising barrel temperature profile with the feed zone at 200–220 °C, the compression zone at 220–245 °C, the metering zone at 230–255 °C, and the nozzle at 240–260 °C. Melt temperature above 270 °C accelerates polybutadiene oxidation and should be avoided. Mould temperature is typically 40–70 °C; higher mould temperatures improve knit-line ductility and surface gloss at the expense of cycle time. Screw geometry with an L/D ratio of 20:1–25:1 and a compression ratio of 2.0:1–2.5:1 is adequate. A general-purpose screw is preferred over aggressive barrier flights because high shear in the metering zone can create dark streaks from decomposed rubber. Injection speed for wall thicknesses between 1.2 mm and 2.5 mm is set by filling studies, commonly 100–200 mm/s; holding pressure is maintained at 60–80% of peak hydraulic pressure until gate freeze. For a projected part area of 100 cm², clamp force requirement is approximately 250–400 kN if cavity pressure does not exceed 40 MPa. This is an approximate moulding envelope; actual values must be established by cavity-pressure curves and dimensional capability studies.

Runner and gate architecture interacts with the high-flow grade. Cold runners should be short and circular or trapezoidal to minimize pressure drop. For a multi-cavity tool, a naturally balanced layout is preferred because ABS melt does not tolerate restrictive artificial tuning of gate lands. Hot-runner systems with valve gates should be purged with SAN or ABS purge compound; polypropylene purge residue can delaminate at the melt interface. Gate diameter for thin-wall parts is typically 0.8–1.5 mm; smaller gates increase shear heating and may cause jetting. Jetting can be controlled by locating the gate to impinge against a cavity wall and by reducing injection speed.

Weld-line strength in HMG94MD is lower than that of MG94MD because the higher-flow architecture has lower molecular weight. At a weld line, notched Izod can fall by 40–60% relative to the bulk value in high-flow ABS; HMG94MD-specific data should be generated for the intended geometry. Therefore, weld lines should not be placed in snap-fit arms, screw bosses, or latch features. If a weld line is unavoidable, increase mould temperature to 70 °C and use a sequential valve-gate system to shift the weld line to a low-stress region. Tensile bars with a weld line should be evaluated under ISO 527-2:2012 at 23 °C and −20 °C to bracket transport and storage conditions.

When Gamma Sterilization Is Specified Instead of Ethylene Oxide Storage

Terminal sterilization by gamma irradiation at 25–50 kGy imposes oxidative stress on the polybutadiene phase and can produce yellowing, tensile strength loss, and notched impact loss. Stabilization packages may be included, but the supplier’s regulatory statement and radiation-tolerance data must be reviewed for the specific grade. Published data for HMG94MD in this specific configuration is limited; therefore, device manufacturers may perform post-irradiation mechanical testing under ASTM D638-14 and ASTM D256-10 after accelerated aging according to ASTM F1980-21. Ethylene oxide sterilization per ISO 11135:2014 is less aggressive to ABS provided that residual gas is reduced to the limits of ISO 10993-7:2008. Steam autoclave processing above 121 °C is outside the practical service window of standard ABS and should not be specified unless the part is unstressed and dimensional distortion is acceptable.

Chemical Contact, Lipid Resistance, and Environmental Stress Cracking

ABS is swollen or dissolved by ketones, esters, aromatic hydrocarbons, and chlorinated solvents. In production cleaning, methyl ethyl ketone, toluene, and trichloroethylene must not be used. Isopropanol and common alcohol-based disinfectants can initiate environmental stress cracking on stressed bosses, snap-fit arms, and ultrasonic welds, particularly when applied as a cold wipe. If alcohol disinfection is required, the part should be evaluated under constant-strain exposure at 0.5% and 1.0% outer-fiber strain using ISO 22088-3:2006 or an equivalent bent-beam fixture. Lipid-based formulations in medical creams can plasticize the SAN phase; compatibility screening is performed according to ISO 175:2010 or ASTM D543-21. Chemical resistance data for pigmented and laser-marked surfaces may differ from natural resin; the finished device must be tested in the exact color and texture condition.

Solvent bonding of HMG94MD is not recommended because methylene chloride and methyl ethyl ketone induce rapid stress cracking. Ultrasonic welding is preferred when the horn and joint geometry are designed for amorphous thermoplastics; welding near gate areas can produce weld flash. Adhesive bonding with cyanoacrylate may be acceptable if service temperature remains below 60 °C; two-part polyurethane adhesives should be evaluated under ASTM D3163-01 because plasticizer migration from the adhesive can weaken the joint.

Regulatory acceptance is device-specific. The resin supplier may provide a regulatory statement indicating biocompatibility test results for unpigmented, injection-moulded plaques; however, final validation must be performed on the finished device under the intended sterilization and clinical exposure conditions. The following matrix identifies reference protocols used in medical-ABS change management.

Regulatory statements for SABIC CYCOLAC HMG94MD must be requested from the supplier and linked to the production lot, because changes in polymerization additives, pigments, or plant location can alter biological reactivity. The responsibility for finished-device biocompatibility under ISO 10993-1:2018 remains with the legal manufacturer.